Welcome to our dedicated page for Movano SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Movano Inc. (Nasdaq: MOVE) SEC filings page on Stock Titan provides direct access to the company’s official regulatory disclosures, along with AI-powered summaries that help explain their contents in plain language. Movano, doing business as Movano Health, files a range of documents with the U.S. Securities and Exchange Commission that together outline its wearable health technology business, capital structure, and significant corporate events.
Investors can review registration statements such as the Form S-1 that describes a committed equity facility with Chardan Capital Markets LLC, including the potential issuance of up to 110,000,000 shares of common stock under the facility and Movano’s status as an emerging growth company and smaller reporting company. The S-1 and related materials also discuss Nasdaq listing matters, reverse stock split effects on share counts, and stockholders’ equity considerations.
Current reports on Form 8-K document material events, including the Agreement and Plan of Merger with Corvex, Inc., the structure of the all-stock combination, expected ownership percentages of the combined company, and conditions to closing. Other 8-K filings cover the one-for-ten reverse stock split, Nasdaq deficiency notices and extensions, amendments to incentive plans, preferred stock financings, amendments to loan agreements, and stockholder meeting results. These filings provide detail on how Movano is addressing listing requirements, financing needs, and its planned transformation through the Corvex merger.
Definitive proxy statements on Schedule 14A offer insight into stockholder votes on matters such as increasing authorized share capital, approving share issuances under the ChEF Purchase Agreement, amending the omnibus incentive plan, and authorizing reverse stock splits. They also describe virtual special meeting logistics and voting procedures for common and preferred stockholders.
On Stock Titan, each filing is accompanied by AI-generated highlights that point out key terms, risk factors, and structural details, helping users navigate lengthy documents like S-1 registration statements and complex 8-K merger disclosures. The platform also makes it easier to locate quarterly and annual reports when filed (Forms 10-Q and 10-K), as well as any insider transaction reports on Form 4, so users can monitor executive and director share dealings once available.
By using this page, investors can quickly find Movano’s official SEC filings related to its wearable medical devices, financing arrangements, Nasdaq compliance efforts, and the proposed renaming and repositioning of the company as Corvex, Inc. after the merger closes, while relying on AI tools to surface the most important information from each document.
Movano Inc. (MOVE) reported an insider transaction on a Form 4. A director and Chief Technology Officer forfeited previously awarded RSUs in lieu of salary and received a stock option grant. On 11/03/2025, the insider disposed of 21,260 shares at a reported price of $0. Following the transaction, the insider directly owned 356 shares of common stock.
Concurrently, the insider was granted 42,250 stock options with an exercise price of $1.25 per share. The grant is contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan, and the option will become exercisable upon that approval. The option carries an expiration date of 12/31/2025.
Movano Inc. (MOVE) disclosed a Form 4 for its CFO, reporting a compensation adjustment on 11/03/2025. The executive forfeited 31,871 restricted stock units at a $0 price in lieu of salary and received a grant of stock options for 84,834 shares with a $1.25 exercise price.
The option becomes exercisable only upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases shares authorized for issuance. The option carries an expiration date of 12/31/2025. Following the transaction, the executive beneficially owned 5,204 shares of common stock directly.
Movano (MOVE) reported an insider compensation change. On 11/03/2025, a director forfeited 13,271 RSUs previously awarded under the Omnibus Incentive Plan, in lieu of directors’ fees, and received a grant of stock options for 35,500 shares at an exercise price of $1.25.
The option award was contingent upon shareholder approval of an amendment to increase shares authorized under the plan; the options will become exercisable upon that approval. After the transaction, the director beneficially owned 1,874 shares of common stock directly.
Movano Inc. agreed to merge with Corvex, Inc., with Corvex becoming a wholly owned subsidiary. Based on an exchange ratio reflecting a $250.0 million valuation for Corvex and $10.0 million for Movano, pre‑merger Corvex holders would own about 96.2% of the combined company and Movano holders about 3.8%, subject to adjustments for concurrent financings and liabilities. An earnout grants additional shares if the volume‑weighted average price exceeds $15.00 and $25.00 per share for 20 of 30 trading days within specified post‑closing periods.
Movano completed a $3.0 million Series A preferred round (convertible at $5.50 per share, capped by a 19.99% beneficial ownership limit) and entered a Chardan committed equity facility of up to $1.0 billion, each subject to stated conditions. Corvex completed a $37.1 million private placement. Closing requires shareholder approvals, S‑4 effectiveness, and Nasdaq listing approval. A loan amendment extends maturity to March 31, 2026, adding a $3.0 million repayment premium upon asset sale before closing and providing for IP transfer to the lender if obligations remain unsatisfied at closing.
Movano Inc. agreed to merge with Corvex, Inc., making Corvex a wholly owned subsidiary and effectively shifting control to Corvex stockholders. Based on the merger’s exchange formula and stated valuations, pre‑merger Corvex holders would own approximately 96.2% of the combined company and pre‑merger Movano holders about 3.8% on a fully diluted basis, before adjustments for related financings. The agreement includes earnouts tied to volume‑weighted average price milestones of $15.00 (within five years) and $25.00 (within seven years).
Movano raised $3.0 million via Series A Preferred Stock and entered a $1.0 billion committed equity facility with Chardan (subject to Nasdaq’s exchange cap, ownership limits, and an effective resale registration). Corvex completed $37.1 million in concurrent private financing. Closing requires stockholder approvals, SEC effectiveness of an S‑4, and Nasdaq listing approval. Support agreements cover 21.2% of Movano shares and certain holders agreed to a 180‑day lock‑up after closing. Movano also extended a loan’s maturity to March 31, 2026; if legacy assets are sold pre‑closing, repayment includes $1.5 million principal plus other obligations and a $3.0 million premium, and if unpaid at closing, Movano’s pre‑closing IP and related assets transfer to the lender.
Movano Inc. (MOVE) reported that on November 3, 2025 it entered into an amendment to its Loan Agreement and Promissory Note with Evie Holdings LLC, originally dated August 6, 2025. The amendment extends the agreement’s maturity date to November 5, 2025.
The company stated the full amendment will be filed as an exhibit to its Annual Report on Form 10‑K for the period ending December 31, 2025.
Movano Inc. director Emily Fairbairn received a grant of 31,028 restricted stock units (RSUs) on
The filing documents a routine equity-based compensation transaction for a director rather than an open-market sale or purchase. The award replaces cash fees with equity, increasing the reporting person's holdings and aligning compensation with share ownership while not showing any cash consideration in the reported transaction.
Movano Inc. filed an amended current report to correct a prior disclosure. The amendment replaces the previously filed Exhibit 3.1 to the October 8, 2025 Form 8-K with the correct version of the Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation, which is stated to be effective October 10, 2025. The filing also lists a press release dated October 8, 2025 as Exhibit 99.1 and includes the cover page interactive data file.
Movano Inc. filed an 8-K disclosing a corporate action dated
The filing text provided here does not state the content of the amendment (for example, changes to authorized shares, classes, or rights), nor does it include financial metrics, transaction terms, or forward-looking statements. Because the filing references an amendment and a contemporaneous press release, investors should review the actual amendment text and the press release for details on what corporate terms changed and any stated rationale or effects on equity structure.
Movano Inc. director Wirk Shaheen received a grant of 20,685 restricted stock units (RSUs) under the company's Omnibus Incentive Plan as payment in lieu of directors' fees for the period
FAQ
What is the current stock price of Movano (MOVE)?
What is the market cap of Movano (MOVE)?
